Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter Study of Gallium Nitrate in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00054808 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.

NCT NCT00054808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00054808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter Study of Gallium Nitrate in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Lead sponsor
Genta Incorporated
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2002
Completion date
Not reported
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate-grade lymphoma, low-grade lymphoma, non-hodgkin's lymphoma, refractory lymphoma, relapsed lymphoma